Comorbidities burden and previous exposure to biological agents may predict drug survival of apremilast for psoriasis in a real‐world setting
Keyword(s):
2018 ◽
Vol 79
(4)
◽
pp. e83-e84
◽
2019 ◽
Vol 31
(4)
◽
pp. 342-343
◽
Keyword(s):
2018 ◽
Vol 30
(2)
◽
pp. 150-151
◽
Keyword(s):
2019 ◽
Vol 46
(7)
◽
pp. 615-617
◽
2018 ◽
Vol 79
(4)
◽
pp. 760-761
◽
2018 ◽
Vol 79
(4)
◽
pp. e85
◽